Home > Boards > US Listed > Biotechs > REATA PHARMACEUTICALS INC [ RETA ] (RETA)

Phase 3 Cardinal Successful Outcome

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Plegee Member Profile
 
Followed By 2
Posts 113
Boards Moderated 0
Alias Born 08/17/06
160x600 placeholder
Reata Provides Update on Omaveloxolone Program for Patients with Friedreich’s Ataxia GlobeNewswire Inc. - 11/24/2020 5:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/18/2020 4:20:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/13/2020 3:45:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 5:05:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/10/2020 6:00:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/10/2020 5:55:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/10/2020 5:43:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/10/2020 5:31:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 5:31:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 6:57:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 6:52:55 AM
Reata Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results and Provides an Update on Business Operations and ... GlobeNewswire Inc. - 11/9/2020 6:45:00 AM
Reata Announces Positive Results From Year 2 of the Pivotal Phase 3 CARDINAL Study of Bardoxolone Methyl in Patients with Alp... GlobeNewswire Inc. - 11/9/2020 6:45:00 AM
Reata Pharmaceuticals, Inc. to Report Third Quarter 2020 Financial Results and Provide an Update on Development Programs on N... GlobeNewswire Inc. - 11/2/2020 5:30:00 PM
Reata Announces Publication of Results From Pivotal Moxie Trial of Omaveloxolone in Patients with Friedreich’s Ataxia GlobeNewswire Inc. - 10/26/2020 7:00:10 PM
Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American Society of Nephrology Kidney Week 20... GlobeNewswire Inc. - 10/15/2020 6:45:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/9/2020 9:16:33 AM
Reata Announces the Presentation of the Pivotal MOXIe Part 2 Study of Omaveloxolone in Friedreich’s Ataxia at the American ... GlobeNewswire Inc. - 9/3/2020 6:45:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 8:01:40 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 3:46:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 6:59:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 6:52:27 AM
Reata Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results and Provides an Update on Business Operations and... GlobeNewswire Inc. - 8/10/2020 6:45:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:42:38 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/4/2020 4:31:57 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences